Evolution of Stereotactic Ablative Radiotherapy in Lung Cancer and Birmingham’s (UK) Experience
Stereotactic ablative radiotherapy (SABR) has taken a pivotal role in early lung cancer management particularly in the medically inoperable patients. Retrospective studies have shown this to be well tolerated with comparable results to surgery and no significant increase in toxicity. Paucity of rand...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2018-07-01
|
| Series: | Medicines |
| Subjects: | |
| Online Access: | http://www.mdpi.com/2305-6320/5/3/77 |
| _version_ | 1811253314714599424 |
|---|---|
| author | Sundus Yahya Qamar Ghafoor Robert Stevenson Steven Watkins Beshar Allos |
| author_facet | Sundus Yahya Qamar Ghafoor Robert Stevenson Steven Watkins Beshar Allos |
| author_sort | Sundus Yahya |
| collection | DOAJ |
| description | Stereotactic ablative radiotherapy (SABR) has taken a pivotal role in early lung cancer management particularly in the medically inoperable patients. Retrospective studies have shown this to be well tolerated with comparable results to surgery and no significant increase in toxicity. Paucity of randomized evidence has dictated initiation of several trials to provide good quality evidence to steer future practice. This review summaries salient developments in lung SABR, comparisons to surgery and other platforms and our local experience at University Hospitals Birmingham, UK of lung SABR since its initiation in June 2013. |
| first_indexed | 2024-04-12T16:48:58Z |
| format | Article |
| id | doaj.art-7d5516ff6da64c0bbb2ebfb36896c4dc |
| institution | Directory Open Access Journal |
| issn | 2305-6320 |
| language | English |
| last_indexed | 2024-04-12T16:48:58Z |
| publishDate | 2018-07-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Medicines |
| spelling | doaj.art-7d5516ff6da64c0bbb2ebfb36896c4dc2022-12-22T03:24:27ZengMDPI AGMedicines2305-63202018-07-01537710.3390/medicines5030077medicines5030077Evolution of Stereotactic Ablative Radiotherapy in Lung Cancer and Birmingham’s (UK) ExperienceSundus Yahya0Qamar Ghafoor1Robert Stevenson2Steven Watkins3Beshar Allos4Hall-Edwards Radiotherapy Research Group, Queen Elizabeth Hospital, Birmingham B15 2TH, UKHall-Edwards Radiotherapy Research Group, Queen Elizabeth Hospital, Birmingham B15 2TH, UKHall-Edwards Radiotherapy Research Group, Queen Elizabeth Hospital, Birmingham B15 2TH, UKHall-Edwards Radiotherapy Research Group, Queen Elizabeth Hospital, Birmingham B15 2TH, UKHall-Edwards Radiotherapy Research Group, Queen Elizabeth Hospital, Birmingham B15 2TH, UKStereotactic ablative radiotherapy (SABR) has taken a pivotal role in early lung cancer management particularly in the medically inoperable patients. Retrospective studies have shown this to be well tolerated with comparable results to surgery and no significant increase in toxicity. Paucity of randomized evidence has dictated initiation of several trials to provide good quality evidence to steer future practice. This review summaries salient developments in lung SABR, comparisons to surgery and other platforms and our local experience at University Hospitals Birmingham, UK of lung SABR since its initiation in June 2013.http://www.mdpi.com/2305-6320/5/3/77lung cancerradiotherapystereotactic ablative radiotherapy (SABR)stereotactic body radiotherapy (SBRT)radiofrequency ablation (RFA)microwave ablationdosimetryradiotherapy treatment techniques |
| spellingShingle | Sundus Yahya Qamar Ghafoor Robert Stevenson Steven Watkins Beshar Allos Evolution of Stereotactic Ablative Radiotherapy in Lung Cancer and Birmingham’s (UK) Experience Medicines lung cancer radiotherapy stereotactic ablative radiotherapy (SABR) stereotactic body radiotherapy (SBRT) radiofrequency ablation (RFA) microwave ablation dosimetry radiotherapy treatment techniques |
| title | Evolution of Stereotactic Ablative Radiotherapy in Lung Cancer and Birmingham’s (UK) Experience |
| title_full | Evolution of Stereotactic Ablative Radiotherapy in Lung Cancer and Birmingham’s (UK) Experience |
| title_fullStr | Evolution of Stereotactic Ablative Radiotherapy in Lung Cancer and Birmingham’s (UK) Experience |
| title_full_unstemmed | Evolution of Stereotactic Ablative Radiotherapy in Lung Cancer and Birmingham’s (UK) Experience |
| title_short | Evolution of Stereotactic Ablative Radiotherapy in Lung Cancer and Birmingham’s (UK) Experience |
| title_sort | evolution of stereotactic ablative radiotherapy in lung cancer and birmingham s uk experience |
| topic | lung cancer radiotherapy stereotactic ablative radiotherapy (SABR) stereotactic body radiotherapy (SBRT) radiofrequency ablation (RFA) microwave ablation dosimetry radiotherapy treatment techniques |
| url | http://www.mdpi.com/2305-6320/5/3/77 |
| work_keys_str_mv | AT sundusyahya evolutionofstereotacticablativeradiotherapyinlungcancerandbirminghamsukexperience AT qamarghafoor evolutionofstereotacticablativeradiotherapyinlungcancerandbirminghamsukexperience AT robertstevenson evolutionofstereotacticablativeradiotherapyinlungcancerandbirminghamsukexperience AT stevenwatkins evolutionofstereotacticablativeradiotherapyinlungcancerandbirminghamsukexperience AT besharallos evolutionofstereotacticablativeradiotherapyinlungcancerandbirminghamsukexperience |